ARTICLE | Clinical News
Substance R (Reticulose): Began Phase I testing
February 28, 2000 8:00 AM UTC
Advanced Viral Research Corp. (ADVR), Yonkers, N.Y. Product: Substance R (Reticulose) Business: Infectious diseases Therapeutic category: Immune modulation Target: CCR5 and CXCR4 chemokine recepto...